Kairos Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Kairos Pharma has a total shareholder equity of $3.3M and total debt of $142.0K, which brings its debt-to-equity ratio to 4.3%. Its total assets and total liabilities are $5.0M and $1.7M respectively.
Key information
4.3%
Debt to equity ratio
US$142.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.22m |
| Equity | US$3.33m |
| Total liabilities | US$1.67m |
| Total assets | US$5.00m |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: KAPA's short term assets ($4.7M) exceed its short term liabilities ($1.7M).
Long Term Liabilities: KAPA has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: KAPA has more cash than its total debt.
Reducing Debt: Insufficient data to determine if KAPA's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: KAPA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: KAPA has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 48.7% each year.